The FDA declared the tirzepatide shortage over in December 2024 and the semaglutide shortage over in February 2025 which should have ended pharmacies' ability to legally compound "copy" versions of the drugs, according to FDA guidance
As the person receiving the B12 injection, you wouldnt be billing Medicare
No published results from the one Phase II trial that was actually conducted
All information regarding mechanisms, reconstitution, dosing math and storage is based on available preclinical research and vendor documentation, but may be inaccurate or incomplete
The batch-specific Certificate of Analysis (COA) is linked on this product page and includes retention time data, purity percentage, molecular weight confirmation by mass spectrometry, and identity verification
BPC-157 Nasal Spray Benefits Direct CNS Delivery: The BPC-157 nasal spray offers potentially more direct access to the central nervous system, crucial for conducting in-depth research on neuroprotection and cognitive functions